Jupiter Neurosciences, Inc.(JUNS)
$1.46-0.06 (-3.95%)
JUNS
Jupiter Neurosciences, Inc. financials statements
$1.46
At close:-0.06 (-3.95%)
Jupiter Neurosciences, Inc. (JUNS) Ratios
229 Followers
Jupiter Neurosciences, Inc. Ratios
JUNS's free cash flow for Q2 2026 was $-2.29M. For the 2026 fiscal year, JUNS's free cash flow was increased by $0.00 and operating cash flow was $-2.29M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.65 | 2.31 | 0.00 | 0.01 | 0.08 |
| Quick Ratio | 0.63 | 2.31 | 0.00 | 0.01 | 0.08 |
| Cash Ratio | 0.51 | 1.88 | 0.00 | 0.01 | 0.06 |
| Solvency Ratio | -1.17 | -1.20 | -0.80 | -0.67 | -0.75 |
| Operating Cash Flow Ratio | -0.73 | -1.95 | -0.08 | -0.17 | -0.31 |
| Short-Term Operating Cash Flow Coverage | -1.02 | -26.71 | -0.24 | -0.72 | -3.94 |
| Net Current Asset Value | $ -2.57M | $ 2.62M | $ -5.92M | $ -7.31M | $ -5.39M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.96 | 0.04 | 15.13 | 8.05 | 0.98 |
| Debt-to-Equity Ratio | -2.90 | 0.05 | -0.39 | -0.27 | -0.13 |
| Debt-to-Capital Ratio | 1.53 | 0.05 | -0.63 | -0.36 | -0.14 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 |
| Financial Leverage Ratio | -3.04 | 1.49 | -0.03 | -0.03 | -0.13 |
| Debt Service Coverage Ratio | -1.60 | -5.55 | -2.04 | -1.71 | -7.69 |
| Interest Coverage Ratio | -134.94 | -12.45 | -17.70 | -4.63 | -34.27 |
| Debt to Market Cap | 0.15 | 0.00 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 11.66 | 0.02 | 0.08 | 0.08 | 0.08 |
| Net Debt to EBITDA | -0.18 | 1.62 | -0.49 | -0.43 | -0.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 80.59% | 0.00% | 0.00% | 100.00% | 100.00% |
| EBIT Margin | -39359.87% | 0.00% | 0.00% | -1807.57% | -640.44% |
| EBITDA Margin | -39359.87% | 0.00% | 0.00% | -1807.57% | -640.44% |
| Operating Profit Margin | -40873.19% | 0.00% | 0.00% | -1471.38% | -612.36% |
| Pretax Profit Margin | -39662.77% | 0.00% | 0.00% | -2125.15% | -658.31% |
| Net Profit Margin | -39662.77% | 0.00% | 0.00% | -2125.15% | -686.39% |
| Continuous Operations Profit Margin | -39662.77% | 0.00% | 0.00% | -2125.15% | -686.39% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 104.27% |
| EBT Per EBIT | 97.04% | 78.92% | 123.58% | 144.43% | 107.50% |
| Return on Assets (ROA) | -155.37% | -39.33% | -3219.34% | -2101.17% | -656.21% |
| Return on Equity (ROE) | 471.92% | -58.48% | 82.46% | 69.39% | 84.58% |
| Return on Capital Employed (ROCE) | 486.32% | -73.72% | 68.83% | 48.86% | 77.94% |
| Return on Invested Capital (ROIC) | -255.45% | -70.42% | 108.95% | 65.43% | 86.32% |
| Return on Tangible Assets | -155.37% | -39.33% | -3219.34% | -2101.17% | -656.21% |
| Earnings Yield | -24.48% | -0.79% | -2.65% | -2.75% | -8.41% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.94 | 0.00 | 0.00 | 1.44 | 3.05 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.99 | 0.96 |
| Working Capital Turnover Ratio | 0.62 | 0.00 | 0.00 | -0.04 | -0.14 |
| Cash Conversion Cycle | 2472.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 13784.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 11312.33 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 13784.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -11.73 | -0.14 | -0.01 | -0.04 | -0.18 |
| Free Cash Flow Per Share | -11.73 | -0.14 | -0.01 | -0.04 | -0.18 |
| Dividend Paid and CapEx Coverage Ratio | -1353434.00 | -977751.00 | -160317.67 | -312126.00 | -433761.50 |
| Capital Expenditure Coverage Ratio | -1353434.00 | -977751.00 | -160317.67 | -312126.00 | -433761.50 |
| Operating Cash Flow Coverage Ratio | -1.02 | -17.96 | -0.21 | -0.66 | -2.66 |
| Operating Cash Flow to Sales Ratio | -248.38 | 0.00 | 0.00 | -5.35 | -2.72 |
| Free Cash Flow Yield | -15.33% | -1.27% | -0.27% | -0.69% | -3.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.08 | -126.18 | -37.73 | -36.41 | -11.89 |
| Price-to-Sales (P/S) Ratio | 1620.54 | 0.00 | 0.00 | 773.71 | 81.63 |
| Price-to-Book (P/B) Ratio | -19.28 | 73.82 | -31.11 | -25.26 | -10.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.52 | -78.75 | -375.28 | -144.57 | -30.02 |
| Price-to-Operating Cash Flow Ratio | -6.52 | -78.75 | -375.28 | -144.57 | -30.02 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | 3.20 | 5.66 | 0.55 | -0.09 |
| Enterprise Value Multiple | -4.30 | -138.93 | -40.02 | -43.24 | -12.82 |
| Enterprise Value | 36.85M | 304.43M | 182.71M | 182.33M | 52.40M |
| EV to EBITDA | -4.30 | -138.93 | -40.02 | -43.24 | -12.82 |
| EV to Sales | 1690.73 | 0.00 | 0.00 | 781.57 | 82.13 |
| EV to Free Cash Flow | -6.81 | -77.84 | -379.89 | -146.03 | -30.20 |
| EV to Operating Cash Flow | -6.81 | -77.84 | -379.89 | -146.03 | -30.20 |
| Tangible Book Value Per Share | -3.97 | 0.14 | -0.18 | -0.22 | -0.55 |
| Shareholders’ Equity Per Share | -3.97 | 0.14 | -0.18 | -0.22 | -0.55 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 |
| Revenue Per Share | 0.05 | 0.00 | 0.00 | 0.01 | 0.07 |
| Net Income Per Share | -18.72 | -0.08 | -0.15 | -0.15 | -0.46 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.04 |
| Interest Burden | 1.01 | 1.11 | 1.05 | 1.18 | 1.03 |
| Research & Development to Revenue | 95.73 | 0.00 | 0.00 | 4.04 | 2.27 |
| SG&A to Revenue | 313.81 | 0.00 | 0.00 | 11.67 | 4.85 |
| Stock-Based Compensation to Revenue | 110.96 | 0.00 | 0.00 | 3.50 | 2.04 |
| Income Quality | 0.63 | 1.60 | 0.10 | 0.25 | 0.41 |
Currency in USD

